Carfilzomib
Product Description
Omnicap GmbH
-
Country/Region:Switzerland
-
On CPHI since:2017
-
Employees:1 - 24
Company types
Categories
Omnicap GmbH
-
Country/Region:Switzerland
-
On CPHI since:2017
-
Employees:1 - 24
Company types
More Products from Omnicap GmbH (99)
-
Product Bortezomib
Proteasome inhibitor API used in hematologic cancers including multiple myeloma and mantle cell lymphoma. -
Product Busulfan
Alkylating antineoplastic API used in leukemia therapy and conditioning regimens before hematopoietic stem-cell transplantation. -
Product Cabazital
Taxane-class microtubule inhibitor API used in oncology, particularly for advanced prostate cancer. -
Product Cabergoline
Long-acting dopamine D2 receptor agonist API used primarily to reduce elevated prolactin levels. -
Product Carbocisteine
Mucoregulating and mucolytic API used to reduce the viscosity of respiratory mucus. -
Product Carboplatin
Platinum-based cytotoxic antineoplastic API used in chemotherapy regimens for multiple solid tumors. -
Product Celecoxib
Selective COX-2 non-steroidal anti-inflammatory API used for pain and inflammatory disorders. -
Product Chromium Picolinate
Organic chromium source used as a nutritional ingredient in mineral and dietary-supplement formulations. -
Product Citicoline Sodium
Choline-donor API used in neurological and cognitive-support formulations and as a precursor for phospholipid synthesis. -
Product Clindamycin Hydrochloride
Lincosamide antibacterial API used for systemic treatment of susceptible bacterial infections. -
Product Clindamycin Phosphate
Water-soluble clindamycin prodrug salt used in topical, injectable and other antibacterial formulations. -
Product Clocortolone Pivalate
Topical corticosteroid API used to reduce inflammation and itching in corticosteroid-responsive dermatoses.